Financial giants have made a conspicuous bearish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 10 unusual trades.
Delving into the details, we found 20% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $217,948, and 7 were calls, valued at $382,311.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $35.0 for Hims & Hers Health during the past quarter.
Volume & Open Interest Trends
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Hims & Hers Health's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Hims & Hers Health's substantial trades, within a strike price spectrum from $15.0 to $35.0 over the preceding 30 days.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | PUT | TRADE | BEARISH | 01/17/25 | $3.3 | $3.1 | $3.26 | $30.00 | $114.1K | 8.5K | 1.1K |
| HIMS | CALL | TRADE | BULLISH | 01/17/25 | $9.3 | $9.2 | $9.3 | $25.00 | $93.0K | 8.5K | 153 |
| HIMS | CALL | SWEEP | BEARISH | 01/16/26 | $16.8 | $16.6 | $16.6 | $20.00 | $78.0K | 3.8K | 75 |
| HIMS | CALL | SWEEP | BEARISH | 05/16/25 | $12.1 | $11.9 | $11.96 | $24.00 | $59.5K | 336 | 54 |
| HIMS | PUT | SWEEP | NEUTRAL | 12/13/24 | $0.65 | $0.45 | $0.55 | $27.00 | $56.9K | 253 | 1.5K |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Hims & Hers Health Standing Right Now?
- Trading volume stands at 8,076,861, with HIMS's price up by 6.42%, positioned at $32.83.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 83 days.
Professional Analyst Ratings for Hims & Hers Health
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $28.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $21. * Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for Hims & Hers Health, targeting a price of $28. * Maintaining their stance, an analyst from Deutsche Bank continues to hold a Hold rating for Hims & Hers Health, targeting a price of $27. * Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Hims & Hers Health with a target price of $38. * An analyst from Canaccord Genuity persists with their Buy rating on Hims & Hers Health, maintaining a target price of $28.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims & Hers Health options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
